* Tabula Rasa HealthCare Inc TRHC.OQ TRHC.O is expected
to show a fall in quarterly revenue when it reports results on
March 6.
* The Moorestown New Jersey-based company is expected to
report
a 5.0% decrease in revenue to $81.391 million from $85.69
million a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data. The company's guidance on
January 17 2023, for the period ended December 31, was for
revenue between $82.00 million and $83.00 million.
* Refinitiv's mean analyst estimate for Tabula Rasa
HealthCare
Inc is for a loss of 6 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Tabula Rasa
HealthCare Inc is $6.5, above its last closing price of $6.11.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2022 -0.19 -0.11 -0.26 Missed -132.1
Jun. 30 2022 -0.17 -0.12 -0.25 Missed -111.9
Mar. 31 2022 -0.16 -0.16 -0.22 Missed -40
Dec. 31 2021 -0.09 -0.08 -0.09 Missed -14.3
Sep. 0.02 0.03 -0.04 Missed -218.5
30 2021
Jun. 30 2021 0.00 0.00 -0.01 Missed -200.3
Mar. 31 2021 -0.09 -0.09 -0.09 Met 2.4
Dec. 31 2020 -0.10 -0.10 -0.08 Beat 17.2
This summary was machine generated March 3 at 21:15 GMT. All
figures in US dollars unless otherwise stated